Literature DB >> 6101377

Acyclovir for suspected systemic herpes infections.

E L Teare, M R Clements.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6101377     DOI： 10.1016/s0140-6736(80)90577-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  A Thr/Ser dual residue motif in the cytoplasmic tail of human CD1d is important for the down-regulation of antigen presentation following a herpes simplex virus 1 infection.

Authors:  Jianyun Liu; Nicole L Glosson; Wenjun Du; Jacquelyn Gervay-Hague; Randy R Brutkiewicz
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

Review 2.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

3.  A candidate live inactivatable attenuated vaccine for AIDS.

Authors:  B K Chakrabarti; R K Maitra; X Z Ma; H W Kestler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.